ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Molecular Assemblies, one of C&EN’s 10 Start-Ups to Watch in 2018, has raised $24 million in series A funding to further develop its enzyme-driven DNA-building technology. Synthetic DNA, used throughout life sciences research, is most often made by chemical reactions that can only create short pieces. Molecular Assemblies says its two-enzyme technology allows for longer stretches of DNA. The company recently entered a partnership with Codexis and is alsocollaborating with GE Research to develop nucleic acid–based therapeutics and vaccines.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter